Skip to main content
Log in

Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Combined oral contraceptive (COC) use is associated with increased risk of developing hypertension. Activation of the intrarenal renin-angiotensin system (RAS) and endothelial dysfunction play an important role in the development of hypertension. We tested the hypothesis that COC causes hypertension that is associated with endothelial dysfunction and upregulation of intrarenal angiotensin-converting enzyme 1 (Ace1) and angiotensin II type 1 receptor (At1r). Female Sprague-Dawley rats aged 12 weeks received (p.o.) olive oil (control) and a combination of 0.1 μg ethinylestradiol and 1.0 μg norgestrel (low COC) or 1.0 μg ethinylestradiol and 10.0 μg norgestrel (high COC) daily for 6 weeks. Blood pressure was recorded by tail cuff plethysmography. Expression of genes in kidney cortex was determined by quantitative real-time polymerase chain reaction. COC treatment led to increased blood pressure, circulating uric acid, C-reactive protein and plasminogen activator inhibitor-1, renal uric acid, and expression of renal Ace1 and At1r. COC treatment resulted in increased contractile responses to phenylephrine in endothelium-denuded aortic rings. Endothelium-dependent relaxation responses to acetylcholine, but not endothelium-independent relaxation responses to nitric oxide (NO) donation by sodium nitroprusside, were attenuated in COC-exposed rings. Impaired relaxation responses to acetylcholine were masked by the presence of NO synthase inhibitor (l-NAME) in the COC-exposed rings, whereas the responses to acetylcholine in the presence of selective cyclooxygenase-2 inhibitor (NS-398) were enhanced. These findings indicate that COC induces hypertension that is accompanied by endothelial dysfunction, upregulated intrarenal Ace1 and At1r expression, and elevated proinflammatory biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, et al. (2005) Oral contraceptives, angiotensin dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care 28:1988–1994

    Article  CAS  PubMed  Google Scholar 

  • Akarasereenont P, Techatraisak K, Thaworn A, Chotewuttakorn S (2000) The induction of cyclooxygenase-2 by 17beta-estradiol in endothelial cells is mediated through protein kinase C. Inflamm Res 49:460–465

    Article  CAS  PubMed  Google Scholar 

  • Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78:6858–6862

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bernstein KE, Ong FS, WL B, Shah KH, Giani JF, Gonzalez-Villalobos RA, et al. (2013) A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev 65:1–46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bieglmayer C, Hofer G, Kainz C, Reinthaller A, Kopp B, Janisch H (1995) Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 9:307–312

    Article  CAS  PubMed  Google Scholar 

  • Bolego C, Cignarella A, Ruzza R, Zaarour C, Messi E, Zanisi M, et al. (1997) Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats. Life Sci 60(25):2291–2302

    Article  CAS  PubMed  Google Scholar 

  • Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW, Kim KC, et al. (2014) Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. FASEB J 28:3197–3204

    Article  CAS  PubMed  Google Scholar 

  • Durand P, Prost M, Blache D (1997) Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity. Arterioscler Thromb Vasc Biol 17(10):1939–1946

    Article  CAS  PubMed  Google Scholar 

  • Franceschini SA, Vieira CS, Martins WP, Franca JB, Ferriani RA (2013) Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium. Contraception 87:766–772

    Article  CAS  PubMed  Google Scholar 

  • Geraghty DP, Byrne KB, McPherson GA, Burcher E (1990) Renal and myocardial adrenoceptors in steroid contraceptive-induced hypertension in rats. Clin Exp Pharmacol Physiol 17:567–578

    Article  CAS  PubMed  Google Scholar 

  • Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN (2008) Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 27:967–978

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giles TD, Sander GE, Nossaman BD, Kadowitz PJ (2012) Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins. J Clin Hypertens (Greenwich) 14:198–205

    Article  CAS  Google Scholar 

  • Giraud GD, Morton MJ, Wilson RA, Burry KA, Speroff L (1996) Effects of estrogen and progestin on aortic size and compliance in postmenopausal women. Am J Obstet Gynecol 174:1708–1717

    Article  CAS  PubMed  Google Scholar 

  • Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M (2005) Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146:834–845

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gonzalez-Villalobos RA, Janjoulia T, Fletcher NK, Giani JF, Nguyen MTX, Riquier-Brison AD, et al. (2013) The absence of intrarenal ACE protects against hypertension. Clin Investig 123(5):2011–2023

    Article  CAS  Google Scholar 

  • Green D (1985) Point: flow-mediated dilation does reflect nitric oxide-mediated endothelial function. J Appl Physiol 99:1233–1234 discussion 1237-1238

    Article  Google Scholar 

  • Griffith JW, Sun T, McIntosh MT, Bucala R (2009) Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol 183:5208–5220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hillard PJ (2005) Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents. Endocrinol Metab Clin North Am 34:707–723

  • Ichida F, Uese K, Hamamichi Y, Hashimoto I, Tsubata S, Fukahara K, et al. (1998) Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension. Acta Paediatr Jpn 40:14–19

    Article  CAS  PubMed  Google Scholar 

  • Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci 84:9265–9269

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Igunnu A, Seok YM, Olatunji LA, Kang SH, Kim IK (2015) Combined oral contraceptive synergistically activates mineralocorticoid receptor through histone code modifications. Eur J Pharmacol 769:48–54

    Article  CAS  PubMed  Google Scholar 

  • Kang DH, Park SK, Lee IK, Johnson RJ (2005) Uric acid-induced C-reactive protein expression implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16:3553–3562

    Article  CAS  PubMed  Google Scholar 

  • Kobori H, Ozawa Y, Satou R, Katsurada A, Miyata K, Ohashi N, et al. (2007) Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Ren Physiol 293(3):F938–F945

    Article  CAS  Google Scholar 

  • Lee WS, Liu CW, Juan SH, Liang YC, Ho PY, Lee YH (2003) Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells. Endocrinology 144:2785–2790

    Article  CAS  PubMed  Google Scholar 

  • Le-Ha C, Beilin LJ, Burrows S, Huang RC, Oddy WH, Hands B, et al. (2013) Oral contraceptive use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence. Eur J Prev Cardiol 20:947–955

    Article  PubMed  Google Scholar 

  • Li M, Kuo L, Stallone JN (2008) Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am J Physiol Heart Circ Physiol 294:H2444–H2455

    Article  CAS  PubMed  Google Scholar 

  • Marcus Y, Shefer G, Stern N (2013) Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance. Mol Cell Endocrinol 378(1–2):1–14

    Article  CAS  PubMed  Google Scholar 

  • Meendering JR, Torgrimson BN, Miller NP, Kaplan PF, Minson CT (2009) Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women. Contraception 79:41–49

    Article  CAS  PubMed  Google Scholar 

  • Merki-Feld GS, Imthurn B, Keller PJ (2000) The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels. Horm Metab Res 32:288–293

    Article  CAS  PubMed  Google Scholar 

  • Miner JA, Martini ER, Smith MM, Brunt VE, Kaplan PF, Halliwill JR (2011) Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women. Am J Phys 301:H1716–H1722

    CAS  Google Scholar 

  • Noone DG, Marks SD (2013) Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. J Pediatr 162:128–132

    Article  CAS  PubMed  Google Scholar 

  • Oestreicher EM, Guo C, Seely EW, Kikuchi T, Martinez-Vasquez D, Jonasson L, et al. (2006) Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II. Kidney Int 70:1759–1768

    Article  CAS  PubMed  Google Scholar 

  • Olatunji LA, Soladoye AO (2008) Oral contraceptive-induced high blood pressure is prevented by renin-angiotensin suppression in female rats but not by sympathetic nervous system blockade. Ind J Exper Biol 46:749–754

    CAS  Google Scholar 

  • Olatunji LA, Usman TO, Seok YM, Kim IK (2016) Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder. Arch Physiol Biochem Early Online: 1–8

  • Plu-Bureau G, Hugon-Rodin J, Maitrot-Mantelet L, Canonico M (2013) Hormonal contraceptives and arterial disease: an epidemiological update. Best Pract Res Clin Endocrinol Metab 27:35–45

    Article  CAS  PubMed  Google Scholar 

  • Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A (2012) Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol 59:235–242

    Article  PubMed  Google Scholar 

  • Ribstein J, Halimi JM, du Cailar G, Mimran A (1999) Renal characteristics and effect of angiotensin suppression in oral contraceptive users. Hypertension 33:90–95

    Article  CAS  PubMed  Google Scholar 

  • Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340:115–126

    Article  CAS  PubMed  Google Scholar 

  • Rossi R, Nuzzo A, Origliani G, Modena MG (2008) Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 51:997–1002

    Article  PubMed  Google Scholar 

  • Roy S (1999) Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives. Am J Obstet Gynecol 180:S364–S368

    Article  CAS  PubMed  Google Scholar 

  • Selim MF, Hussein AF (2013) Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS). Contraception 87:396–403

    Article  CAS  PubMed  Google Scholar 

  • Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, et al. (2009) Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 134:52–58

    Article  PubMed  Google Scholar 

  • Subramanian M, Balasubramanian P, Garver H, Northcott C, Zhao H, Haywood JR, et al. (2011) Chronic estradiol-17beta exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol. Am J Phys 300:R1560–R1568

    CAS  Google Scholar 

  • Szerafin T, Erdei N, Fulop T, Pasztor ET, Edes I, Koller A, et al. (2006) Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res 99:e12–e17

    Article  CAS  PubMed  Google Scholar 

  • Tasic D, Radenkovic S, Kocic G, Ilic MD, Ignjatovic A (2015) Microinflammation factors in the common diseases of the heart and kidneys Dis Markers 2015

  • Virdis A, Schiffrin EL (2003) Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens 12(2):181–187

    Article  CAS  PubMed  Google Scholar 

  • Wadei HM, Textor SC (2012) The role of the kidney in regulating arterial blood pressure. Nat Rev Nephrol 8:602–609

    Article  CAS  PubMed  Google Scholar 

  • Wei W, Li Y, Chen F, Chen C, Sun T, Sun Z, et al. (2011) Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women. J Hum Hypertens 25:364–371

    Article  CAS  PubMed  Google Scholar 

  • Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH (2010) Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 28:1234–1242

    PubMed  Google Scholar 

  • Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, et al. (2008) Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Phys Cell Physiol 295:C1183–C1190

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) (2013R1A1A2058145, and 2013K2A4A1044932), funded by the Ministry of Education, Science and Technology; the Korean Health Technology R&D Project; Ministry of Health and Welfare, Republic of Korea (HI13C1527); and Kyungpook National University Research Fund, 2014.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to In-Kyeom Kim.

Ethics declarations

All procedures were conducted in accordance with the Guiding Principles in the Care and Use of Laboratory Animals and approved by the Institutional Review Board, Kyungpook National University School of Medicine (KNU 2012-116). Every effort was made to minimize both the number of animals used and their suffering.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Lawrence A. Olatunji and Young-Mi Seok contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Olatunji, L.A., Seok, YM., Igunnu, A. et al. Combined oral contraceptive-induced hypertension is accompanied by endothelial dysfunction and upregulated intrarenal angiotensin II type 1 receptor gene expression. Naunyn-Schmiedeberg's Arch Pharmacol 389, 1147–1157 (2016). https://doi.org/10.1007/s00210-016-1272-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-016-1272-0

Keywords

Navigation